Gerard Evan | |
---|---|
Born | [10] | 17 August 1955
Alma mater |
St Peter's College, Oxford King's College, Cambridge [10] |
Known for | Disease Models & Mechanisms |
Awards |
Fellow of the Royal Society (2004) FMedSci (1999) [1] PhD (1982) |
Scientific career | |
Fields |
Cancer
[2]
[3]
[4]
[5]
[6]
[7] Disease biology Myc regulator gene [8] p53 tumour suppressor [9] |
Institutions |
University of Oxford University of Cambridge UCSF [10] [11] Cancer Research UK [12] Ensemble Therapeutics |
Thesis | Monoclonal antibodies as reagents for the analysis of cell surfaces (1982) |
Website |
www labmed |
Gerard Ian Evan FRS, FMedSci (born 17 August 1955) is a British biologist and, since May 2022, Professor of Cancer Biology at King's College London and a principal group leader in the Francis Crick Institute. Prior to this he was Sir William Dunn Professor of Biochemistry and Head of Biochemistry at the University of Cambridge (2009-2022). [11] [13]
Evan was educated at St Peter's College, Oxford, where he studied Biochemistry, and King's College, Cambridge, where he was awarded his PhD in 1982 for research using Monoclonal antibodies. [10] [14]
Evan does research to the determine the molecular basis of cancer. [15] [16] [17] [18] [19] [20] [21] [22]
Prior to Cambridge, Evan was Royal Society Napier Professor at University College London and the Imperial Cancer Research Fund (1988-99), then Gerson & Barbara Bass Bakar Distinguished Professor of Cancer Biology, at University of California, San Francisco (1999-2011).
Gerard Evan | |
---|---|
Born | [10] | 17 August 1955
Alma mater |
St Peter's College, Oxford King's College, Cambridge [10] |
Known for | Disease Models & Mechanisms |
Awards |
Fellow of the Royal Society (2004) FMedSci (1999) [1] PhD (1982) |
Scientific career | |
Fields |
Cancer
[2]
[3]
[4]
[5]
[6]
[7] Disease biology Myc regulator gene [8] p53 tumour suppressor [9] |
Institutions |
University of Oxford University of Cambridge UCSF [10] [11] Cancer Research UK [12] Ensemble Therapeutics |
Thesis | Monoclonal antibodies as reagents for the analysis of cell surfaces (1982) |
Website |
www labmed |
Gerard Ian Evan FRS, FMedSci (born 17 August 1955) is a British biologist and, since May 2022, Professor of Cancer Biology at King's College London and a principal group leader in the Francis Crick Institute. Prior to this he was Sir William Dunn Professor of Biochemistry and Head of Biochemistry at the University of Cambridge (2009-2022). [11] [13]
Evan was educated at St Peter's College, Oxford, where he studied Biochemistry, and King's College, Cambridge, where he was awarded his PhD in 1982 for research using Monoclonal antibodies. [10] [14]
Evan does research to the determine the molecular basis of cancer. [15] [16] [17] [18] [19] [20] [21] [22]
Prior to Cambridge, Evan was Royal Society Napier Professor at University College London and the Imperial Cancer Research Fund (1988-99), then Gerson & Barbara Bass Bakar Distinguished Professor of Cancer Biology, at University of California, San Francisco (1999-2011).